Apixaban Tablet Uses (Fayde / Kis kaam aata hai)
Apixaban (Eliquis) is a Direct Oral Anticoagulant (DOAC) — Factor Xa Inhibitor. Below are all approved uses in Pakistan.
Primary Uses (Mukhya Istemal)
Non-valvular Atrial Fibrillation (AF) — Stroke Prevention
In atrial fibrillation (AF), the heart beats irregularly, which can allow blood clots to form in the left atrium. These clots can travel to the brain and cause a stroke — AF raises stroke risk 5-fold. Apixaban prevents clot formation by blocking Factor Xa. The ARISTOTLE clinical trial demonstrated superior stroke prevention and significantly lower intracranial bleeding with apixaban vs warfarin.
Key Advantage: No INR monitoring required — fixed dose, predictable pharmacokinetics.
DVT and PE Treatment and Prevention
Deep vein thrombosis (DVT) and pulmonary embolism (PE) are serious, potentially life-threatening blood clot conditions. Apixaban was non-inferior to conventional treatment (enoxaparin then warfarin) in the AMPLIFY trial — with a convenient oral route. Can also be continued for recurrence prevention after treatment.
Post-Surgical VTE Prophylaxis
After hip or knee replacement surgery, the risk of venous thromboembolism (VTE) increases significantly. Apixaban 2.5mg BD is prescribed during the surgical recovery period.
Who Should Take It (Kin logon ke liye)
- Stroke prevention in non-valvular AF patients
- After diagnosis of DVT or PE
- After hip/knee replacement surgery
- High risk of recurrent VTE
When NOT to Use (Kab nahi lena chahiye)
- Active significant bleeding
- Mechanical heart valves or antiphospholipid syndrome
- Severe hepatic disease
- Pregnancy
- Apixaban se allergy
Summary
Apixaban is prescribed in Pakistan for AF stroke prevention, DVT/PE treatment, and post-surgical prophylaxis. It is a more convenient DOAC than warfarin but an Rx prescription is required. Use only under doctor's guidance.
The information in this guide is for educational purposes only.